Entos

• Edmonton company receives federal funds to develop COVID-19 vaccine

  Entos Pharmaceuticals has been awarded federal money to conduct the phase 1 clinical trial of Covigenix, its COVID-19 DNA vaccine.

  Canada

  Oct 23, 2020
  
• Alberta COVID-19 vaccine advancing to human testing

  A COVID-19 vaccine developed in Edmonton is moving forward to human trials this summer.

  Health

  Jun 25, 2020
  
• Advertisement
• ‘Maximum protection’: Alberta company developing COVID-19 vaccine

  Entos Pharmaceuticals, Inc. says its DNA-based vaccine would deliver strong protection against COVID-19, and could be mass produced quickly.

  Health

  Mar 23, 2020